Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trabeculectomy with mitomycin C in glaucoma associated with uveitis

J A Prata1, R A Neves, D S Minckler

  • 1Doheny Eye Institute, University of Southern California School of Medicine, Los Angeles.

Ophthalmic Surgery
|September 1, 1994
PubMed
Summary

Mitomycin C (MMC) application during trabeculectomy surgery may improve short-term outcomes for uveitic glaucoma patients. This study found MMC enhanced success rates and reduced intraocular pressure (IOP) in patients with this complex eye condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined robotic approach and enhanced recovery after surgery pathway for optimization of costs in patients undergoing proctectomy.

BJS open·2020
Same author

Prospective evaluation of penetrating deep sclerectomy in advanced open-angle glaucoma: Filtration surgery adapted to resource scarcity in developing countries.

Journal francais d'ophtalmologie·2020
Same author

Baerveldt tube implantation following failed deep sclerectomy versus repeat deep sclerectomy.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2015
Same author

[Trabeculectomy with mitomycin C supplemented with cross-linking hyaluronic acid: a pilot study].

Klinische Monatsblatter fur Augenheilkunde·2010
Same author

Corticosteroid-induced ocular hypertension in draining molteno single-plate implants.

Journal of glaucoma·2009
Same author

Calcification of a molteno implant.

Journal of glaucoma·2009

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Surgical Innovation

Background:

  • Uveitic glaucoma presents a significant challenge in ophthalmology, often requiring surgical intervention.
  • Trabeculectomy is a common surgical procedure for glaucoma, but success rates can be variable, especially in complex cases like uveitic glaucoma.
  • The use of intraoperative antimetabolites like mitomycin C (MMC) is explored to enhance surgical outcomes.

Purpose of the Study:

  • To evaluate the short-term efficacy of intraoperative mitomycin C (MMC) application in trabeculectomy for patients with uveitic glaucoma.
  • To analyze the impact of MMC on intraocular pressure (IOP) control and success rates post-trabeculectomy.
  • To identify and assess complications associated with MMC use in this specific patient population.

Main Methods:

Related Experiment Videos

  • Retrospective evaluation of 24 trabeculectomies performed in 24 patients with uveitic glaucoma.
  • Analysis of intraoperative mitomycin C (MMC) application and its effect on postoperative intraocular pressure (IOP).
  • Assessment of success rates (defined as IOP ≤ 21 mm Hg with or without medication) and complications over a mean follow-up of 9.87 months.

Main Results:

  • 75% of eyes achieved an IOP of 21 mm Hg or less without antiglaucoma medications.
  • An additional 16.6% of eyes reached the target IOP with one antiglaucoma medication.
  • A statistically significant reduction in postoperative IOP was observed (P = .0001).
  • Observed complications included uveitis exacerbation (12.5%), choroidal detachment (12.5%), and hypotony (8.3%).

Conclusions:

  • Intraoperative mitomycin C (MMC) application appears to be a beneficial adjunct for enhancing short-term trabeculectomy success in uveitic glaucoma.
  • MMC can significantly reduce intraocular pressure (IOP) in the short term for these patients.
  • While complications exist, the overall results suggest MMC is a viable option for improving surgical outcomes in challenging cases of uveitic glaucoma.